NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
August 6, 2024 — Alzamend Neuro, Inc. (NASDAQ:ALZN) partners with MGH for Phase II trial of next-generation lithium therapeutic drug candidate for bipolar disorder and Alzheimer's disease, potentially revolutionizing mental health treatment.
August 6, 2024 — Annovis Bio (ANVS) featured in The Bell2Bell Podcast for its transformative therapies targeting Alzheimer’s and Parkinson’s diseases. Learn about the promising phase 3 data of buntanetap and its potential impact on patient care.
August 6, 2024 — Clene (NASDAQ: CLNN) to present at Canaccord Genuity conference, showcasing efforts to treat ALS and MS. Webcast on August 13, 2024. Investors gain valuable insights.
August 6, 2024 — Clene (NASDAQ: CLNN) to present at Canaccord Genuity 44th Annual Growth Conference. Learn about the company's focus on treating ALS and MS. Watch the live webcast for valuable insights.
August 6, 2024 — Citius Pharmaceuticals Inc. (NASDAQ: CTXR) receives approval for a business combination with TenX Keane Acquisition (NASDAQ: TENK), forming Citius Oncology, Inc. The new company will focus on developing and commercializing novel targeted oncology therapies, with LYMPHIR as the first drug to go to market.
August 6, 2024 — Alzamend Neuro, Inc. (NASDAQ:ALZN) is making strides in developing next-generation treatments for mental health disorders, including bipolar disorder and Alzheimer's disease. The company's partnership with Massachusetts General Hospital for Phase II clinical trials of AL001 has the potential to revolutionize treatment options for millions affected by these conditions.
August 6, 2024 — HPS/PayMedix acquires TempoPay to offer a comprehensive healthcare financing and payments solution, addressing health equity, affordability, and the need to simplify the healthcare payments experience.
August 6, 2024 — The Anosh Inc. Foundation, founded by Dr. Anosh Ahmed, announces the largest expansion of philanthropic efforts in its history. New programs in education, healthcare, and community development will address critical issues in underprivileged communities.
August 6, 2024 — CCHR commemorates Purple Heart Day with event honoring U.S. military and veterans, highlighting the issue of psychiatric drugs and their potential link to increased suicides.
August 5, 2024 — Regenerative Medicine Technology Group (OTC: MSSV) is at the forefront of regenerative medicine, offering a wide range of products and services. With the regenerative medicine market projected to grow significantly, savvy investors may find MSSV worth a closer look.
August 5, 2024 — Fraternity Mutual receives 2024 Medical Innovation Award for outstanding contributions to medical technology innovation and application. Learn about the company's breakthroughs in medical data management, patient privacy protection, and AI-powered medical consultation.
August 5, 2024 — Record-breaking heat in California's Sacramento Valley prompts warnings about the dangers of hot pavement to feet. Dr. Phong Le, President of the California Podiatric Medical Association, emphasizes the need for foot protection and immediate medical evaluation if thermal burns occur.
August 3, 2024 — Aleen Inc. is using AI-driven technology to provide personalized health recommendations and empower individuals to proactively manage their health. Learn more about their innovative approach to early health screening.
August 2, 2024 — HeartBeam(NASDAQ: BEAT) to discuss second-quarter 2024 results in conference call and webcast. Learn about the company's VECG technology and its potential impact on cardiac care.
August 2, 2024 — Study reveals the threat of rodenticides to birds of prey. Find out how this news impacts wildlife and the environment. Learn about safer alternatives to protect the ecosystem.
August 2, 2024 — New survey by Hyro reveals patient frustration with provider support and health setbacks. Patients demand more advanced, AI-powered healthcare experiences to reduce pain points and improve interactions with providers.
August 2, 2024 — The MMRF launches the Road to Victories cycling program with Johnson & Johnson support, raising over $2 million since 2017 and committing over $600 million to myeloma research. The program has significantly impacted the life expectancy of myeloma patients with over 15 FDA-approved therapies.
August 1, 2024 — HeartBeam, a medical technology company, will host a conference call to discuss its second-quarter 2024 results. The call, scheduled for Aug. 14, 2024, will cover second-quarter results, regulatory updates, and anticipated 2024 milestones. Access the call and presentation via phone or webcast.
August 1, 2024 — Mothers' Milk Bank California celebrates 50 years of service and launches the Cares Program to provide safe, lifesaving donor milk to at-risk babies. The organization's commitment to quality, efficiency, equity, and education will have a significant impact on families in need.
August 1, 2024 — Theriva Biologics is making strides in oncolytic virus therapies to improve survival rates for difficult-to-treat cancers. Positive results from ongoing clinical trials show promise in treating a wide range of tumor types. This news highlights the company's efforts to address the challenges of treating brain tumors and pancreatic cancers, potentially improving survival rates and providing new treatment options for patients.